Home › Funds › Parkman Healthcare Partners LLC › THC

Parkman Healthcare Partners LLC position in THC

TENET HEALTHCARE CORP · Health Care

Parkman Healthcare Partners LLC reported holding 63,854 shares of THC (TENET HEALTHCARE CORP) in its Q3 2026 13F filing — a position valued at US$16.3M, representing 1.47% of its reported portfolio and ranking #24 among its reported holdings. Parkman Healthcare Partners LLC has disclosed THC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)63.85K sh
Reported value held$16.32M
Portfolio Weight1.47%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's THC position evolved

Parkman Healthcare Partners LLC first disclosed a stake in THC in Q3 2023 at 226,141 shares (US$14.9M). The position peaked in Q1 2024 at 283,853 shares, worth US$29.8M. Across 13 filings, Parkman Healthcare Partners LLC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 63,854 shares valued at US$16.3M — a reduction of -33,426 shares quarter over quarter.. Notable position changes include a 58% increase in Q4 2023 (shares rose 39% over the following quarter), a 99% increase in Q1 2025 (shares rose 31% over the following quarter), a 94% increase in Q2 2026 (shares rose 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 226.14K $14.90M New
Q4 2023 356.81K $26.96M Add
Q1 2024 283.85K $29.84M Reduce
Q2 2024 148.93K $19.81M Reduce
Q3 2024 93.75K $15.58M Reduce
Q4 2024 106.99K $13.50M Add
Q1 2025 213.42K $28.70M Add
Q2 2025 168.88K $29.72M Reduce
Q3 2025 74.33K $15.09M Reduce
Q4 2025 60.51K $12.03M Reduce
Q1 2026 50.12K $9.46M Reduce
Q2 2026 97.28K $18.20M Add
Q3 2026 63.85K $16.32M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About THC and 13F data

THC (TENET HEALTHCARE CORP) is a Health Care company. 35 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$1.04B), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$153.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding THC

All THC fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held THC?

Parkman Healthcare Partners LLC has disclosed THC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Parkman Healthcare Partners LLC's current position in THC?

As of Q3 2026, Parkman Healthcare Partners LLC holds 63.85K shares of THC (TENET HEALTHCARE CORP), valued at $16.32M, representing 1.47% of its reported portfolio and ranking #24.

Has Parkman Healthcare Partners LLC been buying or selling THC?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in THC. The position peaked in Q1 2024 at 283.85K shares.

Which other funds hold THC?

Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.